Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: The Paradigm of Cancer Survivor Bone Health Management.

Cancer therapy-induced bone loss (CTIBL), occurring especially in hormone-treated breast and prostate cancer patients, is a noteworthy long-term consequence of cancer treatments. Because of its negative impact on the quality life of cancer survivors, it deserves much attention. We here summarize the pathophysiology of CTIBL in breast and prostate cancer, its clinical presentation, management, and treatment.

Frontiers of hormone research. 2021 May 04 [Epub ahead of print]

Nicoletta Fortunati, Filippo Gatti, Francesco Felicetti, Enrico Brignardello

SSD Unità di Transizione per Neoplasie Trattate in Età Pediatrica, Turin, Italy.